Microcellular Variant of T-Prolymphocytic Leukemia Mimicking CLL - Sci Forschen Inc.

Article Information

Article Type: Case Report

Citation: Kotchetkov R, Price R (2016) Microcellular variant of T-Prolymphocytic Leukemia mimicking CLL. J Blood Disord Med 1(1): doi http://dx.doi. org/10.16966/jbdm.104

Copyright: © 2016 Kotchetkov R, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Publication history:

 Received date: 21 Nov 2015

 Accepted date: 04 Feb 2016

 Published date:08 Feb 2016

Read More : Here

Published by : Sci Forschen Inc.

The Evolution of the Management of Patients with Dabigatran Associated Hemorrhage - Sci Forschen Inc.

Article Information

Article Type: Short Communication

Citation: Henry BL, Smith RE (2016) The Evolution of the Management of Patients with Dabigatran Associated Hemorrhage. J Blood Disord Med 1(1): doi http://dx.doi.org/10.16966/jbdm.103

Copyright: © 2016 Henry BL, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Publication history:

 Received date: 19 Nov 2015

 Accepted date: 19 Jan 2016

 Published date: 25 Jan 2016

Read More : Here

Published by : Sci Forschen Inc.

Angiomyolipoma Accompanied by Renal Aberrant Artery - Sci Forschen Inc.

Article Information

Article Type: Case Report

Citation: Sancak EB, Gulpinar MT, Akbas A, Resorlu M, Adam G, et al. (2015) Angiomyolipoma accompanying with renal aberrant artery. J Blood Disord Med 1 (1): doi http://dx.doi.org/10.16966/ jbdm.102

Copyright: © 2015 Sancak EB, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Publication history:

 Received date: 16 Nov 2015

 Accepted date: 21 Dec 2015

 Published date: 28 Dec 2015

Read More : Here

Published by : Sci Forschen Inc.

A New World Order in Lymphoma - Checkpoint Inhibitors, Oral Therapies and Maintenance - Sci Forschen Inc.

Article Information

Article Type: Opinion Article

Citation: Mir M (2015) A New World Order in Lymphoma - Checkpoint Inhibitors, Oral Therapies and Maintenance. J Blood Disord Med 1(1): doi http://dx.doi.org/10.16966/jbdm.101

Copyright: © 2015 Mir M. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Publication history:

 Received date: 13 Nov 2015

 Accepted date: 20 Nov 2015

 Published date: 25 Nov 2015


Read More : Here

Published by : Sci Forschen Inc.

Cigarette Smoking and Coagulation-Fibrinolysis Disorders - Sci Forschen Inc.

Article Information

Article Type: Editorial

Citation: Leone A (2015) A Cigarette smoking and coagulation-fibrinolysis disorders . J Blood Disord Med 1(1): doi http://dx.doi.org/10.16966/jbdm.e101

Copyright: © 2015 Leone A. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Publication history:

 Received date: 15 Nov 2015

 Accepted date: 21 Nov 2015

 Published date: 25 Nov 2015


Read More : Here


Published by : Sci Forschen Inc.

Journal of Blood Disorders and Medicine - Sci Forschen

About the Journal

Blood disorders take several lives each year. The medicines for treatment of some of the disorders do exist, but there are still many such disorders for which the treatment is not yet available. Research is going on for those disorders and as soon as some breakthrough is achieved, the medical science will be able to treat some of the incurable diseases. For the researches to be successful, it is important that the flow of information between different researchers is consistent and effective so that they can benefit from each others’ findings. This uninterrupted flow of information and findings is possible through Journal on blood disorder and medicine as the journal published peer reviewed articles on various topics related to blood disorders and their treatment. The content published in the Journal is verified before being published, hence it is quite reliable. The scope of the journal is very vast and covers Acquired Haemolytic anemia, acute basophilic leukemia and monocytic leukemia and so on.

Aim and Scope

Bridging the gap between academia and research through the Sciforschen Journal on blood disorders and medicine
There is a huge pile of data which is generated every day through the researches. These data contain crucial information on the medicines related to blood disorders which can be utilized by scientists for their researches. The articles published in the Sciforschen Journal on blood disorders and medicine aim to provide all the relevant information related to the field of blood disorders and their treatment. The quality of the articles is always maintained and hence all the articles that are submitted by the scholars are peer-reviewed and are also checked by the experts. Only after the credibility of the information is established, they are published in the journal. Journal on blood disorders and medicine understand the importance of the information that the journals provide and hence strive to provide information that is of high quality.

Subjects covered by the Journal of Blood Disorders and Medicine are:

Transfusion Medicine

Blood Components

Stem Cell Transplantation

Apheresis

Gene Based Therapeutics

Blood Collection

Donor Issues

Blood banking logistics Immunohematology

Artificial and Alternative Blood Based Therapeutics


Read More : Here

Published by : Sci Forschen Inc.